Clinical trial
Evaluation of Microglial Activation Using the PET Imaging Ligand [18F]PBR06 in Patients With Amyotrophic Lateral Sclerosis Compared to Healthy Volunteers
NCT03876002 is registered in ClinicalTrials.gov with Molecular NeuroImaging as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Microglial Activation Using the PET Imaging Ligand [18F]PBR06 in Patients With Amyotrophic Lateral Sclerosis Compared to Healthy Volunteers
- Lead sponsor
- Molecular NeuroImaging
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- June 28, 2016
- Completion date
- February 7, 2018
- Enrollment
- 23 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
amyotrophic lateral sclerosis, healthy volunteers